Argitalpenak (34) Ikertzaileren baten partaidetza izan duten argitalpenak

2016

  1. Acute hepatitis C virus re-infection in a heterosexual HIV-positive partner

    Liver International, Vol. 36, Núm. 5, pp. 763

  2. Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1056-1062

  3. Business cycles in a balance-of-payments constrained growth framework

    Economic Modelling, Vol. 57, pp. 120-132

  4. Delta hepatitis: New approaches to therapy

    Future Virology, Vol. 11, Núm. 3, pp. 197-205

  5. El impacto del diseño de actividades en el plagio de Internet en educación superior

    Comunicar: Revista Científica de Comunicación y Educación, Núm. 48, pp. 39-48

  6. Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study

    European Journal of Gastroenterology and Hepatology, Vol. 28, Núm. 8, pp. 923-926

  7. Fuzzy system to adapt web voice interfaces dynamically in a vehicle sensor tracking application definition

    Soft Computing, Vol. 20, Núm. 8, pp. 3321-3334

  8. Geometrical Calibration of X-Ray Imaging with RGB Cameras for 3D Reconstruction

    IEEE Transactions on Medical Imaging, Vol. 35, Núm. 8, pp. 1952-1961

  9. Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis

    Antiviral Therapy, Vol. 21, Núm. 1, pp. 91-92

  10. Hepatitis C cure with antiviral therapy - Beneits beyond the liver

    Antiviral Therapy, Vol. 21, Núm. 1, pp. 1-8

  11. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients

    Journal of Viral Hepatitis, Vol. 23, Núm. 1, pp. 47-52

  12. Hepatitis C virus resistance to the new direct-acting antivirals

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 12, Núm. 10, pp. 1197-1209

  13. High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy

    Antiviral Therapy, Vol. 21, Núm. 6, pp. 489-494

  14. Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

    HIV Medicine, Vol. 17, Núm. 6, pp. 471-478

  15. Human T-lymphotropic virus 1 (HTLV-1) and human T-lymphotropic virus 2 (HTLV-2): Geographical research trends and collaboration networks (1989-2012)

    Revista do Instituto de Medicina Tropical de Sao Paulo, Vol. 58

  16. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection

    Liver International, Vol. 36, Núm. 9, pp. 1258-1266

  17. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596

  18. In search for the open educator: Proposal of a definition and a framework to increase openness adoption among university educators

    International Review of Research in Open and Distance Learning, Vol. 17, Núm. 6, pp. 1-17

  19. Infection-related and -unrelated malignancies, HIV and the aging population

    HIV Medicine, Vol. 17, Núm. 8, pp. 590-600

  20. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5